Relationship between radiochemical purity of 123i-ioflupane and extracranial image captation (parotid and thyroid)
Keywords:
Ioflupane, 123Iodure, Radiocromatography, Radiochemical, Thyroid captation, Thin layer chromatographyAbstract
Aim. The aim of this study is to see the effect of radiochemical purity (PR) of 123I- Ioflupane used for cerebral dopamine transporter SPECT (Single Photon Emission Computed Tomography) on the images and evaluate the possible influence of extravasation during the administration in patient with Parkinson syndrome.
Material and methods. A Prospective study was performed in 39 patients. The PR of 123I-Ioflupane was determined by radiochromatography.
The regions of interest (ROI) were defined in general area of the brain, parotid and cervical region, obtaining the average counts in each region and activity ratios thyroid / brain (RTC) and parotid / brain (RPC). It was proposed a model of multiple linear regression with quantitative and categorical predictors
Results. The model showed that correlation between the PR and the RTC was modified by the presence of extravasation, it was statistically significant (p < 0.001) and predicted the 42.31 % of the variability of the RTC. The correlation between PR and PRC was not modified by any of the variables proposed. The model was statistically significant (p < 0.0176) and 12.3% predicted variability RPC.
Conclusions. The predictive variability of the model of RTC is acceptable and explains the negative impact of extravasation. However, the ability to explain the variability of the PRC is low and should not be attributed to variables studied. A low PR and extravasation during the administration of the radiopharmaceutical involves worse quality of image and increased thyroid irradiation.
Downloads
References
Bajaj N, Hauser RA, Seibyl J, Kupsch A, Plotkin M, Chen C, Grachev ID. Association between Hoehn and Yahr, Mini-Mental State. Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I123 injection (DaTSCAN™) in subjects with clinically uncertain parkinsonian syndromes. Alzheimers Res Ther. 2014 Oct 8;6 (5-8):67.
Ezz Eddin MH, Díaz Platas L, Moreno Frigols JL. Comparación de algunos métodos para el control de calidad del 123IIoflupano. Ars Pharm. 2013; 54(3):48-51.
Menéndez-González M, Tavares F, Zeidan N, Salas-Pacheco JM, Arias-Carrión O. Diagnoses behind patients with hardto-classify tremor and normal DaT-SPECT: a clinical follow up study. Front Aging Neurosci. 2014 Apr 1;6:56.
Ficha técnica Ioflupano 123I en: http://www.ema.europa.
eu/docs/es_ES/document_library/EPAR__Product_Information/
human/000266/WC500035355.pdf. Ge Healthcare Limited. Agencia Española de medicamentos y producto sanitarios. Número de Registro: 00135001
Tavares AS, Batis JC, Papin C, Jennings D, Alagille D, Russell DS, Vala C, Lee H, Baldwin RM, Zubal IG, Marek KL, Seibyl JP, Barret O, Tamagnan GD. Kinetic Modeling, Test-Retest, and Dosimetry of 123I-MNI-420 in Humans. J Nucl Med. 2013;54:1760-1767.
Ficha técnica de Ioduro (123I) de sodio en: http://www.aemps.gob.es/cima/pdfs/es/ft/70420/FT_70420.pdf. Mallinckrodt S.L. Agencia Española de medicamentos y producto
sanitarios. Número de Registro: 70420
Doménech JM, Navarro JB. Regresión múltiple con predictores
categóricos y cuantitativos (7ª ed.) Barcelona: Signo; 2014.
Downloads
Published
How to Cite
Issue
Section
License
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).